Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) shares fell 8.8% during trading on Monday. The stock traded as low as $201.00 and last traded at $202.34. 4,514,914 shares traded hands during trading, a decline of 12% from the average daily volume of 5,138,362 shares. The stock had previously closed at $221.83.
Wall Street Analyst Weigh In
A number of research firms have weighed in on ALAB. Needham & Company LLC decreased their target price on shares of Astera Labs from $425.00 to $300.00 and set a "buy" rating on the stock in a research note on Wednesday, November 4th. Jefferies Financial Group increased their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. BMO Capital Markets assumed coverage on Astera Labs in a report on Thursday, November 5th. They set an "outperform" rating and a $375.00 price target on the stock. Susquehanna decreased their target price on Astera Labs from $310.00 to $258.00 and set a "neutral" rating for the company in a research report on Wednesday, November 4th. Finally, UBS Group dropped their price objective on shares of Astera Labs from $300.00 to $290.00 and set a "neutral" rating on the stock in a research note on Wednesday, November 4th. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $320.85.
Get Our Latest Stock Analysis on Astera Labs
Astera Labs Trading Down 8.8%
The stock has a fifty day simple moving average of $294.27 and a two-hundred day simple moving average of $257.09. The firm has a market cap of $35.36 billion, a PE ratio of 80.61 and a beta of 3.86.
Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share for the quarter, beating analysts' consensus estimates of $1.19 by $0.13. The business had revenue of $584.90 million for the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a net margin of 29.64% and a return on equity of 25.35%. Astera Labs's quarterly revenue was up 153.6% on a year-over-year basis. During the same period last year, the firm posted $0.49 earnings per share. As a group, sell-side analysts predict that Astera Labs, Inc. will post 2.99 earnings per share for the current fiscal year.
Insider Activity
In related news, Director Manuel Alba sold 183,000 shares of the company's stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director directly owned 253,863 shares of the company's stock, valued at $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Thursday, November 5th. The shares were sold at an average price of $211.41, for a total transaction of $1,901,421.54. Following the transaction, the director owned 1,987 shares of the company's stock, valued at $420,071.67. The trade was a 81.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 220,497 shares of company stock valued at $62,043,303 over the last 90 days. 10.40% of the stock is currently owned by company insiders.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the stock. BlackRock Inc. purchased a new position in Astera Labs during the second quarter worth $6,609,581,000. Atreides Management LP lifted its stake in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Van ECK Associates Corp lifted its holdings in shares of Astera Labs by 20.0% during the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company's stock valued at $1,080,980,000 after acquiring an additional 373,545 shares in the last quarter. Bank of America Corp DE acquired a new stake in shares of Astera Labs in the second quarter valued at about $1,061,791,000. Finally, Amundi boosted its holdings in Astera Labs by 77.9% in the first quarter. Amundi now owns 1,880,830 shares of the company's stock valued at $206,139,000 after purchasing an additional 823,477 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.
About Astera Labs
(
Get Free Report)
Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company's portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.